Groww IPO—Should You Apply?
Key IPO Details (at a glance) FYI: Multiple reputable outlets and the issuer’s own updates confirm the Nov 4–7 window, ₹95–₹100 band, and Nov 12 tentative listing. (The Times of India) About the Company Billionbrains Garage Ventures Ltd is the parent of Groww, a leading digital investing platform offering stockbroking, derivatives and commodities trading, IPO/SGB access, and direct mutual funds. It also operates Groww Mutual Fund (formerly Indiabulls AMC)—expanding from pure distribution to asset/wealth management. (Groww) Scale & share: As per RHP/market updates, Groww’s NSE active clients rose from ~5.37 mn (Mar’23) to ~12.6 mn (Jun’25), with ~26.3% market share among NSE active retail clients—nearing Zerodha. (Groww) Revenue mix: Broking remains the engine—~84.5% of FY25 revenue from broking services (RHP). (Groww) Key Management Major Products & Lines of Business Financials / Revenue Snapshot Competitors Direct rivals in discount broking & retail investing include Zerodha, Angel One, Upstox, Dhan; full-service players ICICI Direct, etc. Market-share write-ups underline Groww’s rapid gains in active clients. (Business Standard) Risks & Considerations (What to watch) Valuation & Listing Signals Reports peg an implied valuation of ~₹62,000 crore at the upper band; some coverage notes positive GMP indicating potential double-digit listing gains (unofficial, volatile). Treat GMP only as a sentiment gauge. (The Times of India) Conclusion Groww brings a category-leading retail franchise, rapid client & income growth, and a profitable FY25, while broadening into MTF, LAS, and asset/wealth management. The flip side: heavy broking dependence, intense competition, and regulatory sensitivity. Recommendation For long-term investors: Apply (Moderate). Strong brand, scale economics, and profitability justify a measured subscription, especially if your thesis is on India’s continued financialization and Groww’s cross-sell into MTF/wealth.For listing gains traders: Apply (Tactical) only if you’re comfortable with GMP risk and market mood through Nov 12, 2025. Set exit rules in advance. (mint)
